A core group of differentially expressed genes (FTH1, FTL, HSPA8, HSP90AA1, and HSP90B1) was recurrently identified within significantly enriched pathways across TCGA melanoma samples and clinical cohorts (Fig. 5h). The gene discussed is FTL; the disease is melanoma.